人福医药：10月28日召开董事会会议

Group 1 - The core point of the article is that Renfu Pharmaceutical (SH 600079) held its 11th third board meeting on October 28, 2025, where it reviewed the proposal for establishing the "Regulations Management System" [1] - For the year 2024, the revenue composition of Renfu Pharmaceutical is as follows: pharmaceuticals account for 56.01%, pharmaceutical wholesale and related businesses account for 43.8%, and other businesses account for 0.19% [1] - As of the report date, the market capitalization of Renfu Pharmaceutical is 34.6 billion yuan [1]